Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37

United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

15 insiders · 111 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Muneer A Satter

Director

$43.81M (10)

—

+$43.81M

12,297,112

8.23%

$47.10M

+529.0%

James E Flynn

10% owner

$11.90M (2)

—

+$11.90M

1,617,828

1.08%

$6.20M

—

Bain Capital Life Sciences Investors, LLC entity

10% owner

$7.44M (2)

—

+$7.44M

8,943,554

5.99%

$34.25M

+65.6%

Clarus Lifesciences III, L.P.

10% owner

$3.40M (1)

—

+$3.40M

2,730,635

1.83%

$10.46M

—

Ted Yednock

EVP & Chief Innovation Officer

—

$1.51M (20) scheduled

−$1.51M

184,807

0.1237%

$707.81K

+213.8%

Douglas Love

President and CEO

$246.64K (2)

$819.94K (14) scheduled

−$573.30K

390,476

0.2614%

$1.50M

+1,275%

Jennifer Lew

EVP & Chief Financial Officer

$34.00K (1)

$435.82K (16) scheduled

−$401.82K

170,700

0.1143%

$653.78K

+1,204%

William H. Carson

Director

$374.09K (18)

—

+$374.09K

78,405

0.0525%

$300.29K

—

Jung Choi

Director

$138.27K (1)

—

+$138.27K

33,000

0.0221%

$126.39K

—

Sanjay Chandru Keswani

EVP & Chief Medical Officer

—

$120.51K (1) scheduled

−$120.51K

12,500

0.0084%

$47.88K

—

Michael Overdorf

EVP & Chief Business Officer

—

$118.27K (11)

−$118.27K

182,625

0.1223%

$699.45K

+750.2%

Dean Richard Artis

EVP & Chief Scientific Officer

—

$75.36K (3)

−$75.36K

180,093

0.1206%

$689.76K

+257.8%

Jamie Dananberg

Chief Medical Officer

—

$74.92K (3)

−$74.92K

123,582

0.0827%

$473.32K

—

Redmile Group, LLC entity

10% owner

—

—

—

1,596,222

1.07%

$6.11M

—

Larry Mattheakis

EVP & Chief Scientific Officer

—

—

—

17,188

0.0115%

$65.83K

—